DRIPs -- Dividend reinvestment plans Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : DRIPs -- Dividend reinvestment plans

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Marsh who wrote (33)	12/17/1996 5:42:00 PM
From: Victoria Walley	of 263

My pick, hands down, would be Abbott. More than just a drug or health care company, there seems to always be new activity in at least one of the divisions. There are either new drugs in the pipeline, new products in the diagnostic division, or new consumer products. Over 40% of sales are from outside the US, so there's your international exposure. Moreover, the company just announced a major stock buy-back program. Dividends have been increased annually for years. The drip program is well run, without extra fees. My only complaint would be that optional cash investments are only allowed twice per quarter. SmithKline Beecham does have a drip (it may be an ADR). Vicki

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next